Abstract

Invasive bacterial disease is a major cause of morbidity and mortality in African children. Despite being caused by diverse pathogens, children with sepsis are clinically indistinguishable from one another. In spite of this, most genetic susceptibility loci for invasive infection that have been discovered to date are pathogen specific and are not therefore suggestive of a shared genetic architecture of bacterial sepsis. Here we utilise probabilistic diagnostic models to identify children with a high probability of invasive bacterial disease among critically unwell Kenyan children with P. falciparum parasitaemia. We construct a joint dataset including 1,445 bacteraemia cases and 1,143 severe malaria cases, and population controls, among critically unwell Kenyan children that have previously been genotyped for human genetic variation. Using these data we perform a cross-trait genome-wide association study of invasive bacterial infection, weighting cases according to their probability of bacterial disease. In doing so we identify and validate a novel risk locus for invasive infection secondary to multiple bacterial pathogens, that has no apparent effect on malaria risk. The locus identified modifies splicing of BIRC6 in stimulated monocytes, implicating regulation of apoptosis and autophagy in the pathogenesis of sepsis in Kenyan children.

Data availability

Patient level genotype and phenotype data are available via the European Genome-Phenome Archive, with accession codes EGAD00010000950 (WTCCC2: bacteraemia cases and controls) and EGAD00010000904 (MalariaGEN Consortium: severe malaria cases and controls).Full GWAS summary statistics have been deposited with the GWAS Catalog with accession code GCST90094632.Code and source data underlying each figure (and supplementary figure) are available at: https://github.com/jjgilchrist/Kenya_bacteraemia_malaria

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. James Gilchrist

    Department of Paediatrics, University of Oxford, Oxford, United Kingdom
    For correspondence
    james.gilchrist@paediatrics.ox.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2045-6788
  2. Silvia N Kariuki

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  3. James A Watson

    Malaria, Mahidol Oxford Tropical Medicine Research Unit, Bangkok, Thailand
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5524-0325
  4. Gavin Band

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Sophie Uyoga

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  6. Carolyne M Ndila

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  7. Neema Mturi

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  8. Salim Mwarumba

    .Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  9. Shebe Mohammed

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  10. Moses Mosobo

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  11. Kaur Alasoo

    Institute of Computer Science, University of Tartu, Tartu, Estonia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1761-8881
  12. Kirk A Rockett

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Alexander J Mentzer

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Dominic P Kwiatkowski

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  15. Adrian VS Hill

    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. Kathryn Maitland

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0007-0645
  17. J Anthony G Scott

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7533-5006
  18. Thomas N Williams

    Wellcome Trust Research Programme, Kenya Medical Research Institute, Kilifi, Kenya
    For correspondence
    TWilliams@kemri-wellcome.org
    Competing interests
    The authors declare that no competing interests exist.

Funding

Wellcome Trust (202800)

  • Thomas N Williams

Wellcome Trust (098532)

  • J Anthony G Scott

National Institute for Health and Care Research

  • James Gilchrist

National Institute for Health and Care Research

  • Alexander J Mentzer

Wellcome Trust (223253/Z/21/Z)

  • James A Watson

Wellcome Trust (209265/Z/17/Z)

  • Kathryn Maitland
  • Thomas N Williams

Wellcome Trust (HCUZZ0)

  • Adrian VS Hill

European Research Council (294557)

  • Adrian VS Hill

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: Following explanation of the study, written informed consent was obtained from the parent or guardian of each child included in the study. Ethical approval was obtained from the Kenya Medical Research Institute (KEMRI) National Scientific Steering and Research Committees (approval numbers; SCC1192 and SCC967) and the Oxford Tropical Research Ethics Committee (OxTREC, approval numbers; 020-06 and 014-01).

Copyright

© 2022, Gilchrist et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 640
    views
  • 159
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. James Gilchrist
  2. Silvia N Kariuki
  3. James A Watson
  4. Gavin Band
  5. Sophie Uyoga
  6. Carolyne M Ndila
  7. Neema Mturi
  8. Salim Mwarumba
  9. Shebe Mohammed
  10. Moses Mosobo
  11. Kaur Alasoo
  12. Kirk A Rockett
  13. Alexander J Mentzer
  14. Dominic P Kwiatkowski
  15. Adrian VS Hill
  16. Kathryn Maitland
  17. J Anthony G Scott
  18. Thomas N Williams
(2022)
BIRC6 modifies risk of invasive bacterial infection in Kenyan children
eLife 11:e77461.
https://doi.org/10.7554/eLife.77461

Share this article

https://doi.org/10.7554/eLife.77461

Further reading

    1. Chromosomes and Gene Expression
    2. Genetics and Genomics
    Hans Tobias Gustafsson, Lucas Ferguson ... Oliver J Rando
    Research Article

    Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA synthesis by commonly-used reverse transcriptases (RTs). Here, we benchmark a recently-developed RNA cloning protocol, termed Ordered Two-Template Relay (OTTR), to characterize intact tRNAs and tRNA fragments in budding yeast and in mouse tissues. We show that OTTR successfully captures both full-length tRNAs and tRNA fragments in budding yeast and in mouse reproductive tissues without any prior enzymatic treatment, and that tRNA cloning efficiency can be further enhanced via AlkB-mediated demethylation of modified nucleotides. As with other recent tRNA cloning protocols, we find that a subset of nucleotide modifications leave misincorporation signatures in OTTR datasets, enabling their detection without any additional protocol steps. Focusing on tRNA cleavage products, we compare OTTR with several standard small RNA-Seq protocols, finding that OTTR provides the most accurate picture of tRNA fragment levels by comparison to "ground truth" Northern blots. Applying this protocol to mature mouse spermatozoa, our data dramatically alter our understanding of the small RNA cargo of mature mammalian sperm, revealing a far more complex population of tRNA fragments - including both 5′ and 3′ tRNA halves derived from the majority of tRNAs – than previously appreciated. Taken together, our data confirm the superior performance of OTTR to commercial protocols in analysis of tRNA fragments, and force a reappraisal of potential epigenetic functions of the sperm small RNA payload.

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.